G
Power Law company profile
Ganymed Pharmaceuticals
Biotech & Life Sciences · Mainz, Germany · Founded 2001 Unicorn
Patent intelligence
$223M patent portfolio · 42 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$223M
15.9% of valuation · 2362.4× the top peer Aktis Oncology ($95k)
42 active patent families
Where Ganymed Pharmaceuticals innovates
DiseaseCancer researchOncologyCarcinosisNucleic acid
Above peer median on Legal, Strategic, Market, Technology
Quality vs same-sector peers
Ganymed Pharmaceuticals on the five Patsnap quality dimensions
Ganymed Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Ganymed Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Ganymed Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Ganymed Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.